Skip to main content

Post Doctoral position in Cancer Research at Johns Hopkins University School of Medicine

Cancer Research at Johns Hopkins University School of Medicine
shihie@yahoo.com  suburban Salary will be at the standard level per NIH and Institutional guides.
A postdoctoral position available to study translational aspects iof ovarian and breast cancer research in a multi-disciplinary and highly motivative research environment at Johns Hopkins Medical Institutions. Potential projects include targeting kinase and DNA damaging repair pathways for cancer treatment and microfluidic technique for early detection of cancer. Opportunity to collaborate with our industrial partners, biomedical engineering, bioinformatics, and DNA damaging repair faculties, medical oncologists, and participate in clinical trial studies. Individuals with PhD degree in biological science, experiences in molecular and cellular biology, protein chemistry, immunology and transgenic mouse studies are encouraged to apply. Please see related publications: Cancer Cell. 2015 2015 Jul 13;28(1):82-96; Nucleic Acids Res. 2015 Dec 15;43(22):e154; Nucleic Acids Res. 2015 PMID: 26704972; PLoS Genet. 2014 Oct 30;10(10):e1004751; J Natl Cancer Inst. 2014 Jun 4;106(7); Sci Transl Med. 2014 Feb 19;6(224):224ra24. To apply, please e-mail CV and three names of references to: shihie@yahoo.com and tlw@jhmi.edu

Comments

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcur...

Corona virus (Covid-19)

The only way one can combat with Covid-19 is by building one’s immunity & staying healthy by proper hygiene Best medicines for immunity development could be multivitamin pills with zinc,and best foods could be #freshfruits #vegetables. #Mangoes #lemon #oranges are could be the best.

Biogen to seek approval for high-dose version of Spinal Muscular Atrophy stalwart Spinraza (Nusinersen) after trial win

Biogen, which was first to score an endorsement in Spinal Muscular Atrophy (SMA) in 2016, is endeavoring to address it with a higher portion variant of Spinraza #(Nusinersen). On Wednesday, the organization uncovered that a part of its stage 2/3 Commit concentrate on met its essential endpoint, as a higher portion of Spinraza worked on the engine capability of treatment-innocent newborn children with SMA. The review contrasted the high-portion routine with a coordinated, untreated hoax control bunch from the stage 3 Charm study, which empowered Spinraza's unique endorsement. In the Commit preliminary accomplice, 75 patients were randomized 2:1 to get the higher-portion routine or the FDA-endorsed dose of 12 mg, which incorporates four beginning medicines, trailed by support dosages like clockwork. While the high-portion form of Spinraza met the preliminary's endpoint contrasted with joke, the outcomes too "moved in favor" of the investigational routine contrasted with...